Skip to content

Tenofovir disoproxil-based pill regains its position as first choice for PrEP in the US

Two blue pills being tipped from a pill bottle into a hand.

Huge increase in PrEP uptake when services offer choice and flexibility, African studies show

Dr Elijah Kakande (third from left) at CROI 2023.

HIV infections acquired while on injectable PrEP may take a very long time to be spotted

Dr Susan Eshleman presenting at CROI 2023.

Promising new PrEP method undergoes first safety study for anal sex

Dr Sharon Riddler at CROI 2023.

Good news for women and PrEP: quarterly dosing may work

Professor Mark Marzinke presenting at CROI 2023.

Dapivirine vaginal ring safe to use in third trimester of pregnancy and during breastfeeding

Dr Katherine Bunge at CROI 2023.

Vaccine halves gonorrhoea rate in French study

Professor Jean-Michel Molina at CROI 2023.

Study reveals gatekeeping and stigmatising attitudes towards migrant women among Belgian PrEP professionals

Domizia Salusest | www.domiziasalusest.com

Thai government shuts down key-population led PrEP services

Community activists protesting the changes at the Thai parliament, 16 January 2023. Image from APCOM.